CON
Concentra Group Holdings Parent, Inc.
Medical - Equipment & Services
Market Cap$2.92B
5Y Perf.-2.1%
Compare Stocks
2 / 10Try these comparisons:
Stock Comparison
CON vs ACHC
Revenue, margins, valuation, and 5-year total return — side by side.
ACHC
Acadia Healthcare Company, Inc.
Medical - Care Facilities
Market Cap$2.33B
5Y Perf.-61.0%
CON vs ACHC — Key Financials
Market cap, revenue, margins, and valuation side-by-side.
| Company Snapshot | CON | ACHC |
|---|---|---|
| Industry | Medical - Equipment & Services | Medical - Care Facilities |
| Market Cap | $2.92B | $2.33B |
| Revenue (TTM) | $2.09B | $3.37B |
| Net Income (TTM) | $153M | $-1.11B |
| Gross Margin | 28.4% | 56.2% |
| Operating Margin | 15.5% | 11.7% |
| Forward P/E | 15.6x | 17.0x |
| Total Debt | $1.95B | $2.65B |
| Cash & Equiv. | $183M | $133M |
CON vs ACHC — Long-Term Stock Performance
Price return indexed to 100 at period start. Dividends excluded.
CON
ACHC
| Stock | Jul 24 | May 26 | Return |
|---|---|---|---|
| Concentra Group Hol… (CON) | 100 | 97.9 | -2.1% |
| Acadia Healthcare C… (ACHC) | 100 | 39.0 | -61.0% |
Price return only. Dividends and distributions are not included.
Quick Verdict: CON vs ACHC
Each card shows where this stock fits in a portfolio — not just who wins on paper.
Bottom line: CON leads in 6 of 7 categories, making it the strongest pick for valuation and capital efficiency and profitability and margin quality. Acadia Healthcare Company, Inc. is the stronger pick specifically for growth and revenue expansion. As sector peers, any of these can serve as alternatives in the same allocation.
CON
Concentra Group Holdings Parent, Inc.
The Income Pick
CON carries the broadest edge in this set and is the clearest fit for income & stability and long-term compounding.
- Dividend streak 2 yrs, beta 0.69, yield 52.8%
- 3.2% 10Y total return vs ACHC's -56.7%
- Lower volatility, beta 0.69, current ratio 1.42x
Best for: income & stability and long-term compounding
ACHC
Acadia Healthcare Company, Inc.
The Growth Play
ACHC is the clearest fit if your priority is growth exposure.
- Rev growth 5.0%, EPS growth -5.4%, 3Y rev CAGR 8.3%
- 5.0% revenue growth vs CON's 3.4%
Best for: growth exposure
See the full category breakdown
| Category | Winner | Why |
|---|---|---|
| Growth | ACHC | 5.0% revenue growth vs CON's 3.4% |
| Value | CON | Lower P/E (15.6x vs 17.0x) |
| Quality / Margins | CON | 7.3% margin vs ACHC's -32.8% |
| Stability / Safety | CON | Beta 0.69 vs ACHC's 0.84 |
| Dividends | CON | 52.8% yield; 2-year raise streak; the other pay no meaningful dividend |
| Momentum (1Y) | CON | +6.3% vs ACHC's +6.3% |
| Efficiency (ROA) | CON | 5.4% ROA vs ACHC's -18.6%, ROIC 11.1% vs 5.9% |
CON vs ACHC — Revenue Breakdown by Segment
How each company's revenue is distributed across its business units
Segment breakdown not available.
FY 2025
CON vs ACHC — Financial Metrics
Side-by-side numbers across 2 stocks — who leads on profitability, valuation, growth, and risk.
BEST OVERALLCONLAGGINGACHC
ACHCAcadia Healthcare Com…
1leads
CONConcentra Group Holdi…
5leads
6 Total Categories
CATEGORYLEADERvs ACHCMETRICS WON
Income & Cash FlowRevenue, margins, and cash flow strength
CON5/6
Valuation MetricsMultiples, price ratios, and targets
ACHC4/5
Profitability & EfficiencyROE, ROIC, leverage, and quality scores
CON7/8
Total Returns1Y, 3Y, 5Y total returns with dividends
CON5/6
Risk & VolatilityBeta, volatility, and downside exposure
CON2/2
Analyst OutlookRatings, price targets, and dividends
CON1/1
Income & Cash Flow (Last 12 Months)
CON leads this category, winning 5 of 6 comparable metrics.
Income & Cash Flow (Last 12 Months)
ACHC is the larger business by revenue, generating $3.4B annually — 1.6x CON's $2.1B. CON is the more profitable business, keeping 7.3% of every revenue dollar as net income compared to ACHC's -32.8%. On growth, CON holds the edge at +17.0% YoY revenue growth, suggesting stronger near-term business momentum.
| Metric | CONConcentra Group H… | ACHCAcadia Healthcare… |
|---|---|---|
| RevenueTrailing 12 months | $2.1B | $3.4B |
| EBITDAEarnings before interest/tax | $395M | $588M |
| Net IncomeAfter-tax profit | $153M | -$1.1B |
| Free Cash FlowCash after capex | $176M | -$215M |
| Gross MarginGross profit ÷ Revenue | +28.4% | +56.2% |
| Operating MarginEBIT ÷ Revenue | +15.5% | +11.7% |
| Net MarginNet income ÷ Revenue | +7.3% | -32.8% |
| FCF MarginFCF ÷ Revenue | +8.4% | -6.4% |
| Rev. Growth (YoY)Latest quarter vs prior year | +17.0% | +7.6% |
| EPS Growth (YoY)Latest quarter vs prior year | +5.7% | -49.8% |
CON leads this category, winning 5 of 6 comparable metrics.
Valuation Metrics
ACHC leads this category, winning 4 of 5 comparable metrics.
Valuation Metrics
On an enterprise value basis, ACHC's 8.4x EV/EBITDA is more attractive than CON's 12.6x.
| Metric | CONConcentra Group H… | ACHCAcadia Healthcare… |
|---|---|---|
| Market CapShares × price | $2.9B | $2.3B |
| Enterprise ValueMkt cap + debt − cash | $4.7B | $4.9B |
| Trailing P/EPrice ÷ TTM EPS | 17.55x | -2.08x |
| Forward P/EPrice ÷ next-FY EPS est. | 15.63x | 16.98x |
| PEG RatioP/E ÷ EPS growth rate | — | — |
| EV / EBITDAEnterprise value multiple | 12.62x | 8.40x |
| Price / SalesMarket cap ÷ Revenue | 1.54x | 0.70x |
| Price / BookPrice ÷ Book value/share | 9.79x | 1.07x |
| Price / FCFMarket cap ÷ FCF | 13.90x | — |
ACHC leads this category, winning 4 of 5 comparable metrics.
Profitability & Efficiency
CON leads this category, winning 7 of 8 comparable metrics.
Profitability & Efficiency
CON delivers a 37.4% return on equity — every $100 of shareholder capital generates $37 in annual profit, vs $-41 for ACHC. ACHC carries lower financial leverage with a 1.24x debt-to-equity ratio, signaling a more conservative balance sheet compared to CON's 6.53x.
| Metric | CONConcentra Group H… | ACHCAcadia Healthcare… |
|---|---|---|
| ROE (TTM)Return on equity | +37.4% | -40.9% |
| ROA (TTM)Return on assets | +5.4% | -18.6% |
| ROICReturn on invested capital | +11.1% | +5.9% |
| ROCEReturn on capital employed | +13.8% | +7.5% |
| Piotroski ScoreFundamental quality 0–9 | 5 | 5 |
| Debt / EquityFinancial leverage | 6.53x | 1.24x |
| Net DebtTotal debt minus cash | $1.8B | $2.5B |
| Cash & Equiv.Liquid assets | $183M | $133M |
| Total DebtShort + long-term debt | $2.0B | $2.7B |
| Interest CoverageEBIT ÷ Interest expense | 3.09x | -5.99x |
CON leads this category, winning 7 of 8 comparable metrics.
Total Returns (Dividends Reinvested)
CON leads this category, winning 5 of 6 comparable metrics.
Total Returns (Dividends Reinvested)
A $10,000 investment in CON five years ago would be worth $10,318 today (with dividends reinvested), compared to $3,964 for ACHC. Over the past 12 months, CON leads with a +6.3% total return vs ACHC's +6.3%. The 3-year compound annual growth rate (CAGR) favors CON at 1.0% vs ACHC's -28.4% — a key indicator of consistent wealth creation.
| Metric | CONConcentra Group H… | ACHCAcadia Healthcare… |
|---|---|---|
| YTD ReturnYear-to-date | +17.9% | +77.0% |
| 1-Year ReturnPast 12 months | +6.3% | +6.3% |
| 3-Year ReturnCumulative with dividends | +3.2% | -63.3% |
| 5-Year ReturnCumulative with dividends | +3.2% | -60.4% |
| 10-Year ReturnCumulative with dividends | +3.2% | -56.7% |
| CAGR (3Y)Annualised 3-year return | +1.0% | -28.4% |
CON leads this category, winning 5 of 6 comparable metrics.
Risk & Volatility
CON leads this category, winning 2 of 2 comparable metrics.
Risk & Volatility
CON is the less volatile stock with a 0.69 beta — it tends to amplify market swings less than ACHC's 0.84 beta. A beta below 1.0 means the stock typically moves less than the S&P 500. CON currently trades 92.4% from its 52-week high vs ACHC's 83.8% drawdown — a narrower gap to the peak suggests stronger recent price momentum.
| Metric | CONConcentra Group H… | ACHCAcadia Healthcare… |
|---|---|---|
| Beta (5Y)Sensitivity to S&P 500 | 0.69x | 0.84x |
| 52-Week HighHighest price in past year | $24.68 | $30.20 |
| 52-Week LowLowest price in past year | $18.55 | $11.43 |
| % of 52W HighCurrent price vs 52-week peak | +92.4% | +83.8% |
| RSI (14)Momentum oscillator 0–100 | 56.1 | 46.1 |
| Avg Volume (50D)Average daily shares traded | 637K | 3.3M |
CON leads this category, winning 2 of 2 comparable metrics.
Analyst Outlook
CON leads this category, winning 1 of 1 comparable metric.
Analyst Outlook
Wall Street rates CON as "Buy" and ACHC as "Buy". Consensus price targets imply 35.8% upside for CON (target: $31) vs -7.1% for ACHC (target: $24). CON is the only dividend payer here at 52.80% yield — a key consideration for income-focused portfolios.
| Metric | CONConcentra Group H… | ACHCAcadia Healthcare… |
|---|---|---|
| Analyst RatingConsensus buy/hold/sell | Buy | Buy |
| Price TargetConsensus 12-month target | $31.00 | $23.50 |
| # AnalystsCovering analysts | 4 | 25 |
| Dividend YieldAnnual dividend ÷ price | +52.8% | — |
| Dividend StreakConsecutive years of raises | 2 | 1 |
| Dividend / ShareAnnual DPS | $12.05 | — |
| Buyback YieldShare repurchases ÷ mkt cap | +0.5% | +2.1% |
CON leads this category, winning 1 of 1 comparable metric.
Key Takeaway
CON leads in 5 of 6 categories (Income & Cash Flow, Profitability & Efficiency). ACHC leads in 1 (Valuation Metrics).
Best OverallConcentra Group Holdings Pa… (CON)Leads 5 of 6 categories
Loading custom metrics...
CON vs ACHC: Frequently Asked Questions
10 questions · data-driven answers · updated daily
01Is CON or ACHC a better buy right now?
For growth investors, Acadia Healthcare Company, Inc.
(ACHC) is the stronger pick with 5. 0% revenue growth year-over-year, versus 3. 4% for Concentra Group Holdings Parent, Inc. (CON). Concentra Group Holdings Parent, Inc. (CON) offers the better valuation at 17. 6x trailing P/E (15. 6x forward), making it the more compelling value choice. Analysts rate Concentra Group Holdings Parent, Inc. (CON) a "Buy" — based on 4 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.
02Which has the better valuation — CON or ACHC?
On forward P/E, Concentra Group Holdings Parent, Inc.
is actually cheaper at 15. 6x.
03Which is the better long-term investment — CON or ACHC?
Over the past 5 years, Concentra Group Holdings Parent, Inc.
(CON) delivered a total return of +3. 2%, compared to -60. 4% for Acadia Healthcare Company, Inc. (ACHC). Over 10 years, the gap is even starker: CON returned +3. 2% versus ACHC's -56. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.
04Which is safer — CON or ACHC?
By beta (market sensitivity over 5 years), Concentra Group Holdings Parent, Inc.
(CON) is the lower-risk stock at 0. 69β versus Acadia Healthcare Company, Inc. 's 0. 84β — meaning ACHC is approximately 22% more volatile than CON relative to the S&P 500. On balance sheet safety, Acadia Healthcare Company, Inc. (ACHC) carries a lower debt/equity ratio of 124% versus 7% for Concentra Group Holdings Parent, Inc. — giving it more financial flexibility in a downturn.
05Which is growing faster — CON or ACHC?
By revenue growth (latest reported year), Acadia Healthcare Company, Inc.
(ACHC) is pulling ahead at 5. 0% versus 3. 4% for Concentra Group Holdings Parent, Inc. (CON). On earnings-per-share growth, the picture is similar: Concentra Group Holdings Parent, Inc. grew EPS -8. 5% year-over-year, compared to -537. 4% for Acadia Healthcare Company, Inc.. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.
06Which has better profit margins — CON or ACHC?
Concentra Group Holdings Parent, Inc.
(CON) is the more profitable company, earning 8. 8% net margin versus -33. 3% for Acadia Healthcare Company, Inc. — meaning it keeps 8. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: CON leads at 16. 0% versus 11. 7% for ACHC. At the gross margin level — before operating expenses — CON leads at 27. 8%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.
07Is CON or ACHC more undervalued right now?
On forward earnings alone, Concentra Group Holdings Parent, Inc.
(CON) trades at 15. 6x forward P/E versus 17. 0x for Acadia Healthcare Company, Inc. — 1. 4x cheaper on a one-year earnings basis. Analyst consensus price targets imply the most upside for CON: 35. 8% to $31. 00.
08Which pays a better dividend — CON or ACHC?
In this comparison, CON (52.
8% yield) pays a dividend. ACHC does not pay a meaningful dividend and should not be held primarily for income.
09Is CON or ACHC better for a retirement portfolio?
For long-horizon retirement investors, Concentra Group Holdings Parent, Inc.
(CON) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0. 69), 52. 8% yield). Both have compounded well over 10 years (CON: +3. 2%, ACHC: -56. 7%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.
10What are the main differences between CON and ACHC?
Both stocks operate in the Healthcare sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.
In terms of investment character: CON is a small-cap deep-value stock; ACHC is a small-cap quality compounder stock. CON pays a dividend while ACHC does not, making them suitable for different income and tax situations. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.
Find Stocks Like These
Explore pre-built screens for each stock's profile, or build a custom screen to find stocks that outperform both.
Revenue Growth>
%
(CON: 17.0% · ACHC: 7.6%)You Might Also Compare
Based on how these companies actually compete and overlap — not just which sector they're filed under.